Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME

Journal of Experimental & Clinical Cancer Research(2024)10.1186/s13046-024-03214-5Source: DataRank Database

Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME is a research paper published in Journal of Experimental & Clinical Cancer Research (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

geo doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: goldTopics (20)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Varsha Thakur ORCID,Kathryn M LaPorte,Vijay S. Thakur ORCID,Brian Flores,Valentina Caicedo

Live enrichment

PubMed:39491031 PMC:PMC11533310

Bankhead-Coley Foundation

Grant: 23B15

Melanoma Research Alliance

Grant: 826156

NIH/NCI

Grant: P30AI073961

NIH/NCI

Grant: P30CA240139

NIAID NIH HHS

Grant: T32 AI162624

goldLicense: cc-by

publisherhttps://jeccr.biomedcentral.com/counter/pdf/10.1186/s13046-024-03214-5

publisherhttps://link.springer.com/content/pdf/10.1186/s13046-024-03214-5.pdf

publisherhttps://link.springer.com/article/10.1186/s13046-024-03214-5/fulltext.html

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11533310/pdf/13046_2024_Article_3214.pdf

repositoryhttps://doaj.org/article/02f457d9d27b4896be22ab657b8b7584

Fields of Study

AnimalsMiceReceptor, Notch1HumansMelanomaImmunotherapyAntibodies, NeutralizingTumor MicroenvironmentCell Line, TumorFemale

MeSH Terms

Cell Line, TumorAnimalsHumansMiceMelanomaImmunotherapyFemaleReceptor, Notch1Antibodies, NeutralizingTumor Microenvironment

Additional file 1 of Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME

10.6084/m9.figshare.27600982.v1figshare

Additional file 1 of Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME

10.6084/m9.figshare.27600982figshare